Homocysteine and Venous Thrombosis: Outline of a Vitamin Intervention Trial

ABSTRACT

In the past years several case-control studies established the association of an elevated plasma homocysteine concentration and the risk of venous thromboembolism. It is still unclear if elevated homocysteine concentrations can cause venous thrombosis. The VITRO (VItamins and ThROmbosis) trial is the first multicenter, randomized, double-blind and placebo-controlled study to evaluate the effect of homocysteine-lowering therapy by means of 5 mg folic acid, 0.4 mg vitamin B ₁₂ and 50 mg vitamin B₆. The study is a secondary prevention trial in 600 patients who suffered from a first episode of idiopathic deep vein thrombosis (DVT) or pulmonary embolism (PE), or both. There will be 300 hyperhomocysteinemic and 300 normohomocysteinemic patients included, all with an objectivated venous thrombosis. The end point is recurrence of venous thrombosis.

KEYWORD

Homocysteine - hyperhomocysteinemia - venous thrombosis - vitamin treatment - multicenter trial

REFERENCES

• 1 Anderson F A, Wheeler H B, Goldberg R J. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study .  Arch Intern Med . 1991;  151 933-938
• 2 Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population.  J Intern Med . 1992;  232 155-160
• 3 Koster T, Rosendaal F R, Briet E. Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study).  Blood . 1995;  85 2756-2761
• 4 Koster T, Blann A D, Briet E, Vandenbroucke J P, Rosendaal F R. Role of clotting factor VIII in effect of von Willebrand factor on occurence of deep-vein thrombosis.  Lancet . 1995;  345 152-155
• 5 Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.  Blood . 1996;  88 3698-3703
• 6 Rosendaal F R, Koster T, Vandenbroucke J P, Reitsma P H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance).  Blood . 1995;  85 1504-1508
• 7 Wilcken D EL, Wilcken B. The pathogenesis of coronary artery disease-a possible role for methionine metabolism.  J Clin Invest . 1976;  57 1079-1082
• 8 Boushey C J, Beresford S A, Omenn G S, Motulsky A G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.  JAMA . 1995;  274 1049-1057
• 9 Brattstrom L, Tengborn L, Lagerstedt C, Israelsson B, Hultberg B. Plasma homocysteine in venous thromboembolism.  Haemostasis . 1991;  21 51-57
• 10 Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P. Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters.  Thromb Res . 1993;  70 123-129
• 11 Falcon C R, Cattaneo M, Panzeri D, Martinelli I, Mannucci P M. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.  Arterioscler Thromb . 1994;  14 1080-1083
• 12 den Heijer M, Blom H J, Gerrits W B. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? .  Lancet . 1995;  345 882-885
• 13 den Heijer M, Koster T, Blom H J. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.  N Engl J Med . 1996;  334 759-762
• 14 Amundsen T, Ueland P M, Waage A. Plasma homocysteine levels in patients with deep venous thrombosis.  Arterioscler Thromb Vasc Biol . 1995;  15 1321-1323
• 15 Fermo I, Vigano' D A, Paroni R. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.  Ann Intern Med . 1995;  123 747-753
• 16 Cattaneo M, Martinelli I, Mannucci P M. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.  N Engl J Med . 1996;  335 974-975
• 17 Simioni P, Prandoni P, Burlina A. Hyperhomocysteinemia and deep-vein-thrombosis.  Thromb Haemost . 1996;  76 883-886
• 18 Ridker P M, Hennekens C H, Selhub J. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.  Circulation . 1997;  95 1777-1782
• 19 Eichinger S, Stumpflen A, Hirschl M. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism .  Thromb Haemost . 1998;  80 566-569
• 20 den Heijer M, Rosendaal F R, Blom H J, Gerrits W BJ, Bos G MJ. Hyperhomocysteinemia and venous thrombosis: A meta-analysis.  Thromb Haemost . 1998;  80 874-877
• 21 Mudd S H, Skovby F, Levy H L. The natural history of homocystinuria due to cystathionine-beta-synthase deficiency.  Am J Hum Genet . 1985;  37 1-31
• 22 Wilcken D E, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment.  J Inherit Metab Dis . 1997;  20 295-300
• 23 Homocysteine Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials.  BMJ. 1998;  316 894-898
• 24 den Heijer M, Brouwer I A, Bos G MJ. Vitamin supplementation reduces blood homocysteine levels: A controlled trial in patients with venous thrombosis and healthy volunteers.  Arterioscler Thromb Vasc Biol . 1998;  18 356-361
• 25 den Heijer M, Bos G MJ, Gerrits W BJ, Blom H J. Will a decrease of blood homocysteine by vitamin supplementation reduce the risk for vascular disease?.  Fibrinolysis . 1994;  91-92 (91-92)
• 26 Willems H PJ, Bos G MJ, Gerrits W BJ. Acidic citrate stabilizes blood samples for assay of total homocysteine .  Clin Chem . 1998;  44 342-345
• 27 Ubbink J B, Vermaak W J, van der Merwe A, Becker P J. The effect of blood sample aging and food consumption on plasma total homocysteine levels.  Clin Chim Acta . 1992;  207 119-128
• 28 Prandoni P, Cogo A, Bernardi E. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis.  Circulation . 1993;  88 1730-1735
• 29 Koopman M MW, Jongbloets L MM, Lensing A WA, Buller H R, ten Cate J W. Clinical utility of a quantitative B-mode ultrasonography method in patients with suspected recurrent deep-vein thrombosis (DVT).  Thromb Haemost. 1993;  69 623
• 30 Schulman S, Rhedin A-S, Lindmarker P. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism.  N Engl J Med . 1995;  332 1661-1665